ICON Announces Collaboration to Develop New Translational Medicine Unit at Purpose-built Hospital Facility in Manchester Read more about ICON Announces Collaboration to Develop New Translational Medicine Unit at Purpose-built Hospital Facility in Manchester
ICON Selected to Manage Lilly Clinical Trial Site Set Up and Monitoring in Europe Read more about ICON Selected to Manage Lilly Clinical Trial Site Set Up and Monitoring in Europe
ICON Acquires Assets of Qualia Clinical Services, Inc. Read more about ICON Acquires Assets of Qualia Clinical Services, Inc.
ICON Reports 9% Increase in Revenue, 25% Increase in EPS and Acquisition of a U.S. Phase I Facility Read more about ICON Reports 9% Increase in Revenue, 25% Increase in EPS and Acquisition of a U.S. Phase I Facility
ICON Announces Appointment of Dr. Anthony J. Murphy to the Board of Directors Read more about ICON Announces Appointment of Dr. Anthony J. Murphy to the Board of Directors
ICON Completes CAP Accreditation of its Central Laboratories in Singapore and India Read more about ICON Completes CAP Accreditation of its Central Laboratories in Singapore and India
ICON and MedAvante Sign Alliance Agreement Read more about ICON and MedAvante Sign Alliance Agreement
ICON reports Full-Year 2008 revenue growth of 37% operating income growth of 44% and EPS growth of 38% (NASDAQ:ICLR) (ISIN:IE0005711209) Read more about ICON reports Full-Year 2008 revenue growth of 37% operating income growth of 44% and EPS growth of 38% (NASDAQ:ICLR) (ISIN:IE0005711209)
ICON Delivers New Electronic Solution to Expedite Clinical Trial Adjudication Read more about ICON Delivers New Electronic Solution to Expedite Clinical Trial Adjudication
ICON Recognised as Research Company of the Year at the PharmaTimes Awards Read more about ICON Recognised as Research Company of the Year at the PharmaTimes Awards
